Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $952000.0.

  • Dna X's Depreciation & Amortization (CF) rose 370.37% to $952000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 330.65%. This contributed to the annual value of $3.6 million for FY2024, which is 6124.21% up from last year.
  • Latest data reveals that Dna X reported Depreciation & Amortization (CF) of $952000.0 as of Q3 2025, which was up 370.37% from $797000.0 recorded in Q2 2025.
  • Dna X's Depreciation & Amortization (CF)'s 5-year high stood at $1.8 million during Q4 2022, with a 5-year trough of $67000.0 in Q3 2023.
  • Over the past 5 years, Dna X's median Depreciation & Amortization (CF) value was $630000.0 (recorded in 2023), while the average stood at $687947.4.
  • Per our database at Business Quant, Dna X's Depreciation & Amortization (CF) tumbled by 7184.3% in 2022 and then skyrocketed by 127014.93% in 2024.
  • Dna X's Depreciation & Amortization (CF) (Quarter) stood at $498000.0 in 2021, then soared by 265.46% to $1.8 million in 2022, then tumbled by 47.47% to $956000.0 in 2023, then fell by 4.39% to $914000.0 in 2024, then grew by 4.16% to $952000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $952000.0 in Q3 2025, compared to $797000.0 in Q2 2025 and $1.1 million in Q1 2025.